Financial Enhancement Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $465K | Buy |
4,502
+4
| +0.1% | +$413 | 0.07% | 106 |
|
|
2025
Q1 | $428K | Buy |
4,498
+12
| +0.3% | +$1.14K | 0.07% | 99 |
|
|
2024
Q4 | $424K | Buy |
4,486
+38
| +0.9% | +$3.6K | 0.06% | 100 |
|
|
2024
Q3 | $239K | Sell |
4,448
-37
| -0.8% | -$1.99K | 0.05% | 111 |
|
|
2024
Q2 | $337K | Buy |
4,485
+22
| +0.5% | +$1.65K | 0.05% | 101 |
|
|
2024
Q1 | $304K | Buy |
4,463
+15
| +0.3% | +$1.02K | 0.05% | 106 |
|
|
2023
Q4 | $271K | Hold |
4,448
| – | – | 0.05% | 103 |
|
|
2023
Q3 | $223K | Hold |
4,448
| – | – | 0.04% | 116 |
|
|
2023
Q2 | $225K | Hold |
4,448
| – | – | 0.04% | 116 |
|
|
2023
Q1 | $239K | Hold |
4,448
| – | – | 0.05% | 111 |
|
|
2022
Q4 | $212K | Hold |
4,448
| – | – | 0.04% | 114 |
|
|
2022
Q3 | $172K | Hold |
4,448
| – | – | 0.04% | 103 |
|
|
2022
Q2 | $166K | Hold |
4,448
| – | – | 0.04% | 103 |
|
|
2022
Q1 | $197K | Hold |
4,448
| – | – | 0.04% | 102 |
|
|
2021
Q4 | $189K | Hold |
4,448
| – | – | 0.03% | 104 |
|
|
2021
Q3 | $193K | Hold |
4,448
| – | – | 0.04% | 101 |
|
|
2021
Q2 | $190K | Hold |
4,448
| – | – | 0.04% | 93 |
|
|
2021
Q1 | $172K | Hold |
4,448
| – | – | 0.04% | 93 |
|
|
2020
Q4 | $160K | Hold |
4,448
| – | – | 0.03% | 100 |
|
|
2020
Q3 | $170K | Hold |
4,448
| – | – | 0.04% | 93 |
|
|
2020
Q2 | $156K | Hold |
4,448
| – | – | 0.04% | 96 |
|
|
2020
Q1 | $145K | Hold |
4,448
| – | – | 0.04% | 96 |
|
|
2019
Q4 | $201K | Hold |
4,448
| – | – | 0.05% | 79 |
|
|
2019
Q3 | $181K | Hold |
4,448
| – | – | 0.05% | 77 |
|
|
2019
Q2 | $191K | Buy |
+4,448
| New | +$191K | 0.06% | 86 |
|